10.2015 | 34th ESOPRS meeting

esoprs2015

 

Dear ESOPRS Members and Colleagues;

On behalf of the ESOPRS committee, you are cordially invited to join the 34nd annual meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS) in Brussels from 10-12 September 2015.

The Pre-Meeting course will be held on Thursday, September 10, and will have an special emphasis on update and controversies in Ophthalmic Plastic and Reconstructive Surgery. The course will take place in the same venue of the Meeting.

On Friday and Saturday, The Annual ESOPRS Meeting will take place in the Hospital Saint Luc.

The Meeting will include oral, poster presentations and videos in all major topics. The scientific programm will also include round tables and lectures by internationally renowned speakers from Europe and overseas, with topics ranging from clinical practice to the latest scientific thoughts, and where delegates will get the opportunity to exchange ideas and update themselves on novelties in Opthalmic Plastic and Reconstructive Surgery.

Your interaction with colleagues from different countries will stimulate a creative exchange of ideas and will contribute to a successful and enjoyable meeting. We also hope and trust that you will enjoy your visit to the very beautiful city of Brussels.

Best wishes
Lelio Baldeschi
Local organizer

Thuesday September 10th 2015
PRE-MEETING COURSE: “PEARLS AND CONTROVERSIES IN ORBITAL, LACRIMAL AND OPHTHALMIC PLASTIC SURGERY”
8.25-8.30 Welcome and opening

8.30-10.20 Session: Oculoplastic and Orbital Oncology
8.30-8.45 Periocular tumors and principles of lid reconstruction. J Lasudry (Be)
8.45-9.00 Periocular tumors when Medical treatment is possible. C Hintschich (D)
9.00-9.20 Surgical approaches to orbital neoplasms. G Rose (UK)
9.20-9.40 Secondary tumors to the orbit. M Hamoir (Be)
9.40-10.00 Paediatric orbital tumors. L Baldeschi (Be)
10.00-10.20 Medical treatment of paediatric orbital neoplasms. J Merx (NL)

10.20-10.35 Coffee break (poster and exhibition area)

10.35-11.25 Special interest symposium: “Facial Palsy”
10.35-11.05 Pathophysiology of facial palsy and facial reanimation. G Salimbeni (I)
11.05-11.25 The role of the ophthalmic plastic surgeon in facial palsy. D Surace (I)

11.25-12.55 Session: Periocular Aesthetic and lid function
11.25-11.45 Aestetic medical peri-ocular treatments. R Migliardi (I)
11.45-12.05 Aesthetic surgery of the peri-ocual region. J Olver (UK)
12.05-12.20 Upper eyelid asymmetry, different causes. V de Groot (Be)
12.20-12.35 Role of frontalis muscle flap in ptosis correction. Analysis and case scenario. R Medel (E)
12.35-12.55 The presentation and management of eyelid causes of tearing. J Hurwitz (Ca)

12.55-13.15 Morning Discussion: round table with all the morning speakers

13.15-14.00 Lunch

14.00-15.00 Session: Socket
14.00-14.20 Enucleation and eviscerations. R Guthoff (D)-
14.20-14.40 Enucleation for choroidal melanoma: is it still an option in 2015? P De Potter (Be)
14.40-15.00 Prosthetic rehabilitation in adults and kids. A Modugno (I)

15.00-16.00 Special interest symposium: “Graves’ Orbitopathy”
15.00-15.20 An overview on Graves’ orbitopathy and ethnic differences of the disease. Seah Ley Leng (Singapore)
15.20-15.40 Graves’ orbitopathy: when and which medical treatments can be considered. C Marcocci (I)
15.40-16.00 Surgical treatment of Graves’ orbitopathy for reversing disfigurement or sight threatening disease. D Kikkawa (USA)

16.00-16-15 Coffee break (poster and exhibition area)

16.15-16.30 Session: Perls for aspiring orbitologists
16.15-16.30 When orbit meets neurophthalmology. A Boschi (Be) –
16.30-16.45 Surgical anatomy and management of the orbital apex lesions. P Saeed (NL)
16.45-17.00 Idiopathic Orbital Inflammation: Short and Sweet. I Mombaerts (Be)
17.00-17.15 Update on IgG4 an emerging orbital and systemic disorders. D Paridaens (NL)
17.15-17.30 Congenital lacrimal drainage system occlusions. P Jonkeer (Be)

17.30-17.50 Afternoon Discussion: round table with all the afternoon speakers
17.50-17.55 Closing remarks
18.00-19.00 Committee meeting

ESOPRS 34th annual meeting

Friday 11th September

8.00-8.30 Rapid Fire Presentations (orbit)

8.00-8.03 LESSONS LEARNT FROM A CASE OF STEROID DEPENDENT ORBITAL INFLAMMATION. V Joganathan, UK
– 8.03-8.06 AGE RELATED CHANGES IN THE KOREAN PEDIATRIC HUMAN ORBIT ON CT. H Ahn, South Korea
8.06-8.09 MALIGNANT PLEURAL MESOTHELIOMA WITH LACRIMAL GLAND METASTASIS. G Vandekerckhove, The Netherlands
8.09-8.12 COMPRESSIVE OPTIC NEUROPATHY IN IPILIMUMAB-INDUCED ORBITAL INFLAMMATION. M Zmuda, France
8.12-8.15 EARLY DIFFERENTIAL DIAGNOSIS OF RHINO-ORBITO-CEREBRAL MUCORMYCOSIS AND BACTERIAL ORBITAL CELLULITIS. S Lee, South Korea
8.15-8.18 ORBITAL AND PERIORBITAL COMPLICATIONS OF PROTON BEAM RADIATION THERAPY FOR INTRAOCULAR TUMORS. J ParK, South Korea
8.18-8.21 MORPHOLOGICAL AND ULTRASOUND FEATURES OF HYALURONIC ACID GEL DISTRIBUTION IN ORBIT. Y Grusha, Russia
8.21-8.24 PROSTAGLANDIN ASSOCIATED ENOPHTHALMOS: AN OBSERVER-MASKED RADIOLOGICAL STUDY OF PATIENTS TREATED WITH PROSTAGLANDIN DROPS TO ONE EYE ONLY. V Joganathan, UK
8.24-8.27 EFFECT OF ORBITAL DECOMPRESSION ON CORNEAL TOPOGRAPHY IN PATIENTS WITH THYROID OPHTHALMOPATHY. Y Sung, South Korea
8.27-8.30 DOES DIFFUSION WEIGHTED IMAGING HAVE A ROLE IN IDENTIFYING AND MONITORING CLINICAL ACTIVITY IN GRAVES’ ORBITOPATHY. F Rahman, UK

8.30-8.35 Welcome

8.35-9.30 Free paper Orbit I
Chairs D Paridaens, Y Ntountas
8.35-8.41 UPPER FORNIX APPROACH COMBINED WITH A SUPERIOR LATERAL CANTHOLYSIS – A MINIMALLY INVASIVE APPROACH TO THE SUPERONASAL INTRACONAL SPACE. H Sa, South Korea
8.41-8.47 CRANIOFACIAL FIBROUS DYSPLASIA: 28 CASES. S Genders, The Netherlands
8.47-8.53 RISK OF RETINOPATHY AFTER RADIATION TREATMENT FOR OCULAR LYMPHOMA AND ORBITAL TUMOURS A CASE SERIES. A Rahim, UK
8.53-8.59 ANTERIOR SEGMENT COMPLICATIONS OF HIGH-DOSE ORBITAL RADIOTHERAPY. S Gores, UK
8.59-9.05 REDUCTION OF DELAYED COMPLEX ORBITAL FRACTURES WITH AN ENDOSCOPE-NAVIGATION SYSTEM—A PRELIMINARY REPORT ON A NEW TECHNIQUE SHOWING HIGH ACCURACY AND EFFICACY. Y Li, Cina
9.05-9.11 SARCOID-ASSOCIATED OPTIC NEUROPATHY. A Dharmasena, UK
9.11-9.17 IMMUNOGLOBULIN G (IGG) SUBCLASS SEROLOGY IN IGG4-RELATED ORBITAL DISEASE. S Shen, Sigapore

9.17-9.30 Discussion
9.30-10.00 Key note lecture B Lengéle (Be) “Facial transplantation state of the art and perspectives”

10.00-10.20 Coffe break (Poster & Exibition Area)

10.20-11.40 Free paper Orbit II & Graves’ Orbitopathy

10.20-10.26 ORBITAL FINE-NEEDLE ASPIRATION BIOPSY: A RETROSPECTIVE REVIEW OF 225 CASES. E DAFGÅRD KOPP, Sweden

10.26-10.32 OUTCOME OF A STUDY RELATING TO THE EFFICACY OF IMIQUIMOD AS A PREOPERATIVE ADJUNCTIVE TREATMENT IN PERIOCULAR BASAL CELL CARCINOMA. A Malik, UK

10.32-10.38 DEBULKING BUT NOT REMOVING OPTIC NERVE GLIOMAS FOR DISFIGURING PROPTOSIS: A GLOBE-SPARING APPROACH BY LATERAL ORBITOTOMY ALONE. W Katowitz, USA
10.38-10.44 PRIMARY MALIGNANT NEOPLASMS OF THE EXTRAOCULAR MUSCLES IN ADULTS. A Dharmasena, UK
10.44-10.50 NATIONAL THYROID EYE DISEASE (TED) AUDIT. F Mellington, UK
10.50-10.56 TEMPORAL HOLLOWING AFTER LATERAL WALL DECOMPRESSION OF PATIENTS WITH THYROID EYE DISEASE. H Ueland, Norway
10.56-11.02 UNIQUE FEATURES OF THYROID ASSOCIATED ORBITOPATHY AMONG INDIANS WHEN COMPARED TO CAUCASIANS. S Mallajosyula, India
11.02-11.08 ORBITAL DECOMPRESSION WITH PRECISE DESIGN, REFINE MANIPULATION AND ACCURATE VERIFICATION. H Zhou, China
11.08-11.14 OVEREXPRESSION OF COLLAGEN XIII IN THYROID-ASSOCIATED OPHTHALMOPATHY AFFECTED EXTRAOCULAR MUSCLES – MORE PIECES OF THE PUZZLE. O Morris, Sweden

11.14-11.20 CONSTITUTIVELY LOW EXPRESSION OF COLLAGEN XIII ALPHA 1 MAY HELP EXPLAIN THE VULNERABILITY OF THE INFERIOR RECTUS MUSCLE TO THYROID-ASSOCIATED OPHTHALMOPATHY. O Morris, Sweden

11.20-11.40 Discussion

11.40-12.35 Free paper Eyelids I

11.40-11.46 ANTERIOR APPROACH WHITE LINE ADVANCEMENT: A MINIMALLY INVASIVE TECHNIQUE FOR PTOSIS CORRECTION. S Sagili, UK
11.46-11.52 POSTERIOR APPROACH PTOSIS REPAIR FOLLOWING TRABECULECTOMY. J Oestreicher, Canada
11.52-11.58 DEFINING THE ROLE OF SECONDARY INTENTION HEALING IN FULL-THICKNESS LID MARGIN DEFECTS. J Morton, UK
11.58-12.04 VALIDATION OF THE FACIAL ASSESSMENT BY COMPUTER EVALUATION (FACE) PROGRAM FOR SOFTWARE-AIDED EYELID MEASUREMENTS. CJ Choi, USA
12.04-12.10 SKIN FIBROBLASTS ISOLATED FROM THE UPPER EYELID AND STERNUM DIFFER IN THEIR MATRIX CONTRACTION POTENTIAL AND THEIR RESPONSE TO INFLAMMATORY CYTOKINES. J Roos, UK
12.10-12.16 ECCRINE ADENOCARCINOMA OF EYELID: REPORT OF THREE CASES. M Rondon Benavente, Spain
12.16-12.22 SIMULTANEOUS VERSUS SEQUENTIAL PTOSIS AND STRABISMUS SURGERY IN CHILDREN. K Revere, USA

12.22-12.35 Discussion

12.35-13.30 Lunch

13.30-14.10 Mustardè Lecture V Thaller (UK) “More or less…”

14.10-15.10 Free paper Eyelids II

14.10-14.16 EPIDEMIOLOGICAL ANALYSIS AND CLINICO- PATHOLOGICAL CORRELATION OF EYE LID LESIONS: 20 YEARS’ EXPERIENCE AT A TERTIARY EYE CARE CENTRE. K Koka, India

14.16-14.22 EVALUATION OF TISSUE LOSS IN OCT-GUIDED EXCISION OF BCC INVOLVING EYELID MARGINS. C Miller, Germany
14.22-14.28 COMPARING THE EFFECT OF LEVATOR ADVANCEMENT AND CONJUNCTIVAL-MULLERECTOMY PTOSIS SURGERY ON TEAR PRODUCTION AND DRY EYE SYMPTOMS. V. Yin, Canada
14.28-14.34 SURVEY OF BRITISH OCULOPLASTIC SURGERY SOCIETY (BOPSS) CONSULTANTS IN THE SURGICAL MANAGEMENT OF PTOSIS AND THE USE OF PHENYLEPHRINE. M Mota, UK
14.34-14.40 REVERSE PTOSIS CORRECTION BY LOWER-EYELID CONJUNCTIVAL-MÜLLERECTOMY. O Balaguer Sole, Spain

14.40-14.46 TREATMENT WITH DOXYCYCLINE FOR SEVERE BORTEZOMIB-INDUCED BLEPHARITIS. M Veys, Belgium

14.46-14.52 OPHTHALMIC TRIGEMINAL TROPHIC SYNDROME: THE CHALLANGE OF CICITRACIAL PERIOCULAR SKIN CHANGES. A Hassan, UK

14.52-14.58 MALIGNANT EYELID TUMORS AND BIOPSY TECHNIQUES-A CLINICOPATHOLOGIC STUDY OF 2384 LESIONS. L Holbach, Germany

14.58-15.10 Discussion

15.10-15.30 Key note lecture D Kikkawa (USA) “The challenging and changing landscape of facial aesthetic surgery”

15.30-15.50 Coffe break (Poster & Exibition Area)

15.50-16.00 Junior Award

16.00-16.45 Free paper Lacrimal I

16.00-16.06 IMMUNOPATHOLOGY AND HISTOPATHOLOGY OF CONJUNCTIVAL BIOPSIES IN PATIENTS WITH PUNCTAL STENOSIS. R Allen, USA
16.06-16.12 MICROENDOSCOPY; REDUCED INVASIVENESS IN CANALICULAR SURGERY. T Suzuki, Japan
16.12-16.18 NASOLACRIMAL DUCT OBSTRUCTION, A BILATERAL DISEASE? G Missotten, Belgium
16.18-16.24 OPTICAL COHERENCE TOMOGRAPHY IMAGING OF THE PROXIMAL LACRIMAL SYSTEM. J Wawrzynski, UK
16.24.16.30 COMPARISON IN ACTIVITY LIMITATIONS IN DAILY LIFE BETWEEN PATIENTS WITH EPIPHORA AND CATARACT. E Bohman, Sweden

16.30-16.36 THE ADVANTAGES OF AUGMENTING GENERAL ANAESTHESIA WITH LOCAL ANAESTHESIA IN LACRIMAL SURGERY: A PROSPECTIVE MASKED STUDY. R Scawn, UK

16.36-16.45 Discussion

16.45-17.05 Key note lecture S Lay Leng (Singapore) “Proteomic of tears in lacrimal gland tumors and other orbital diseases”

17.05 Annual General assembly

20.30 Gala Dinner

*****

Saturday 12th September

8.00-8.30 Rapid Fire Presentation (orbit, lids, and lacrimal)

8.00-8.03 HISTOPATHOLOGICAL CHANGES IN INVOLUTIONAL LOWER EYELID ENTROPION. D Miletic, Croatia
8.03-8.06 OUTCOME OF POSTERIOR APPROACH WHITE-LINE ADVANCEMENT PTOSIS REPAIR: THE PRESTON EXPERIENCE. V Patel, UK
8.06-8.09 MANAGEMENT OF LARGE ORBITAL IMPLANT EXPOSURE WITH DERMIS FAT GRAFT. S Liao, Taiwan
8.09-8.12 A REVIEW OF 31 LACRIMAL GLAND LESIONS: CASE OF CLINICO-RADIOLOGIC MISDIAGNOSIS HIGHLIGHTS CRITICAL ROLE OF BIOPSY. B Skippen, UK
8.12-8.15 PERIOCULAR BASAL CELL CARCINOMA: 4-YEAR REVIEW OF DATA AND CONFIRMATION OF THE EFFICACY OF RAPID PARAFFIN SECTIONS WITH DELAYED RECONSTRUCTION. S Tavassoli, UK
8.15-8.18 A CASE OF NAEVUS OF OTA WITH ORBITAL MELANOMA. T Van Den Bosch, The Netherlands
8.18-8.21 SPATIAL RELATIONSHIP BETWEEN PROTOPORPHYRIN FLUORESCENCE INTENSITY AND IRON DISTRIBUTION IN BASAL CELL CARCINOMA (FIRST RESULTS). N Kiryushenkova, Russia
8.21-8.24 OPHTHALMIC MANIFESTATIONS OF GRANULOMATOSIS WITH POLYANGIITIS. IV Abramova, Russia
8.24-8.27 ANALYSIS OF CORRELATION BETWEEN THE DURATION OF TEARING SYMPTOM AND THE VERTICAL SIZE OF LACRIMAL SAC IN PATIENTS WITH PRIMARY NASOLACRIMAL DUCT OBSTRUCTION. J Park, South Korea
8.27-8.30 USE OF THE LAC-Q QUESTIONNAIRE TO STANDARDISE EVALUATION OF DACROCYSTORHINOSTOMY SUCCESS RATES. F McGregor UK

8.30-9.15 Free paper Lacrimal II

8.30-8.36 EPIPHORA TREATMENT BY NASOLACRIMAL DUCT DECOMPRESSION: AN ALTERNATIVE TO DCR. M Kataev, Russia
8.36-8.42 THE SURVIVAL OF AN ANGLED EXTENDED JONES’ TUBE. E Witters, Belgium
8.42-8.48 SURGICAL OUTCOME AND UNUSUAL COMPLICATIONS OF PAEDIATRIC EXTERNAL DCR. F Quarantaleoni, Italy
8.48-8.54 FIBRIN GLUE FOR ENDONASAL DACRYOCYSTORHINOSTOMY: A NEW METHOD OF ASSISTING MARSUPIALIZATION IN ENDOSCOPIC ENDONASAL DACRYOCYSTORHINOSTOMY. N Tsurumaru, Japan

8.54-9.00 HOW USEFUL IS LACRIMAL SCINTIGRAPHY (DSG) IN THE ASSESSMENT OF PATIENTS WITH EPIPHORA AND PATENT NON-FUNCTIONING LACRIMAL SYSTEMS? . Vonica, UK

9.00-9.06 OCULAR ADNEXAL TRAUMA. T Leivo, Finland

9.06-9.15 Discussion

9.15-9.45 Key note lecture J Hurwitz (Ca) “40 years of lacrimal surgery what had changed which the perspectives”

9.45-10.05 Coffe break

10.05-10.50 Free paper Periocular Aesthetic & Miscellanea

10.05-10.11 TRANSBLEPHAROPLASTY SUBORBICULARIS MIDFACE LIFT. J Schiller, USA
10.11-10-17 INDICATIONS OF TRANSCONJUNCTIVAL MIDFACE LIFTING. 13 YEARS EXPERIENCE. M Rondon Benavente, Spain
10.17-10.23 A MATHEMATICAL MODEL TO QUANTIFY & EVALUATE THE EYELID CONTOUR. H Ilhan, Turkey

10.23-10.29 COMPARATIVE STUDY OF MICRODISSECTION NEEDLES VERSUS COLD SCALPEL IN UPPER EYELID BLEPHAROPLASTY. Y Arat, Turkey

10.29-10.35 TRANSDERMAL NANO-ENABLED ANAESTHETICS FOR EYELID SURGERY. K Emeriewen, UK
10.35-10.41 A NOVEL ADAPTATION OF A POINT-OF-VIEW (POV) ACTION CAMERA FOR VIDEO RECORDING OF OCULOPLASTIC PROCEDURES FROM THE SURGEON’S TRUE PERSPECTIVE. V Kratky, Canada
10.41-10.50 Discussion

10.50-11.10 Key note lecture D Verity (UK) “When to biopsy the enlarged extraocular muscles”

11.10-12.35 Free paper Anophthalmic Socket & Orbit

11.10-11.16 CURRENT SOCKET DISEASE PREVALENCE AND MANAGEMENT IN NORTHERN ENGLAND. J Laybourne, UK
11.16-11.22 PROSTHESIS MOVEMENTS EVALUATION – A NEW METHOD USING PHOTOSHOP SOFTWARE. Y Vardizer, Israel
11.22-11.28 FILLERS: NOT ONLY FOR RITHIDIS. R Migliardi, Italy
11.28-11.34 THE TREATMENT OF CONJUNCTIVAL CYSTS OF THE ANOPHTHALMIC SOCKET. M Unal, Turkey
11.34-11.40 NON SURGICAL PROCEDURE TO RESHAPE INFERIOR FORNIX IN CONTRACTED SOCKET. A Modugno, Italy
11.40-11.46 ASSESSMENT OF TEAR PRODUCTION AND SEVERITY OF DISCHARGE IN SUBJECTS WITH ACQUIRED ANOPHTHALMIC SOCKET; A CASE CONTROL STUDY. A Heirati, Iran
11.46-11.52 LACRIMAL DRAINAGE SYSTEM OBSTRUCTION IN SUBJECTS WITH ACQUIRED ANOPHTHALMIC SOCKET; A DOUBLE MASKED CASE CONTROL STUDY. M Kashkouli, Iran
11.52-11.58 THE INCIDENCE OF OCULOPLASTIC SURGERY FOLLOWING PRIMARY ENUCLEATION. A Renfigo Coolman, The Netherlands
11.58-12.04 EARLY, YET TOO LATE: THE PERINEURAL INVASION. K Chaloupka, Switzerland
12.04-12.10 MYDRIASIS DURING ORBITAL SURGERY: SHOULD I WORRY? P Shams, UK

12.10-12.16 THE OPPORTUNITIES OF VIRTUAL ENDOSCOPY OF THE ORBIT IN GRADE IV UVEAL MELANOMA.O Zykov, Russia

12.16-12.30 Discussion

12.45-13.00 Closing Remarks

13.00-14.00 Lunch

Call Now Button